MetaCap

MaxCyte Insider Trades

NASDAQ: MXCTHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD

0.9821-0.0579 (-5.58%)

Market open · Delayed 15 min · as of Oct 8, 12:46 PM ET

Last 12 months

Purchases
0 · $0
Sales
1 · $8.27K
Shares bought / sold
0 / 10.14K
Net activity
Net selling $8,266

MaxCyte insider activity

Over the last 12 months, MaxCyte insiders reported 11 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $8,266 worth of stock, for net insider selling of $8,266. The largest seller was Swirsky Douglas J, with $8,266 in reported sales.

The most recent filing shows Hemrajani Rekha (Director) reporting a transaction in 30,421 shares on Jun 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MXCT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

MXCT insider transactions

MaxCyte insider transactions
DateInsiderTypeSharesValueFiling
Jun 17, 2026Al-Wakeel Yasir B.DirectorAward30,421—Form 4
Jun 17, 2026BALTHROP PATRICK JDirectorAward30,421—Form 4
Jun 17, 2026Brooke William WDirectorAward30,421—Form 4
Jun 17, 2026Collins CynthiaDirectorAward30,421—Form 4
Jun 17, 2026Erck Stanley CDirectorAward30,421—Form 4
Jun 17, 2026Johnston John JosephDirectorAward30,421—Form 4
Jun 17, 2026DOUGLAS RICHARDDirectorAward30,421—Form 4
Jun 17, 2026Hemrajani RekhaDirectorAward30,421—Form 4
Apr 15, 2026Ahuja ParmeetChief Financial OfficerAward187,500—Form 4
Mar 27, 2026Masoud MaherPresident and CEOAward300,000—Form 4
Mar 17, 2026Swirsky Douglas JCHIEF FINANCIAL OFFICERSale10,142$8.27KForm 4
Aug 13, 2025Erck Stanley CDirectorBuy100,000$137.22KForm 4
Aug 13, 2025Brooke William WDirectorBuy50,000$64.50KForm 4
Aug 13, 2025DOUGLAS RICHARDDirectorBuy80,000$111.04KForm 4
Aug 13, 2025Masoud MaherPresident and CEOBuy75,000$102.92KForm 4
Aug 13, 2025Swirsky Douglas JCHIEF FINANCIAL OFFICERBuy50,000$64.50KForm 4
Jun 25, 2025Hemrajani RekhaDirectorSale10,684$22.38KForm 4
Jun 18, 2025Al-Wakeel Yasir B.DirectorAward29,210—Form 4
Jun 18, 2025BALTHROP PATRICK JDirectorAward29,210—Form 4
Jun 18, 2025Brooke William WDirectorAward29,210—Form 4
Jun 18, 2025Collins CynthiaDirectorAward29,210—Form 4
Jun 18, 2025Erck Stanley CDirectorAward29,210—Form 4
Jun 18, 2025Hemrajani RekhaDirectorAward29,210—Form 4
Jun 18, 2025DOUGLAS RICHARDDirectorAward29,210—Form 4
Jun 18, 2025Johnston John JosephDirectorAward29,210—Form 4
Mar 18, 2025Soleymannezhad AliChief Commercial OfficerSale1,211$3.85KForm 4
Mar 18, 2025Swirsky Douglas JCHIEF FINANCIAL OFFICERSale6,939$22.06KForm 4
Mar 18, 2025Sandoval David I.GENERAL COUNSELSale353$1.12KForm 4
Mar 14, 2025Soleymannezhad AliChief Commercial OfficerAward34,625—Form 4
Mar 14, 2025Swirsky Douglas JCHIEF FINANCIAL OFFICERAward37,500—Form 4
Mar 14, 2025Sandoval David I.GENERAL COUNSELAward23,125—Form 4
Jan 27, 2025Johnston John JosephDirectorSale3,000$13.94KForm 4
Jan 27, 2025Johnston John JosephDirectorOption exercise3,000$8.80KForm 4
Jan 13, 2025Sandoval David I.GENERAL COUNSELSale4,466$20.27KForm 4
Dec 26, 2024Johnston John JosephDirectorSale3,000$12.02KForm 4
Dec 26, 2024Johnston John JosephDirectorOption exercise3,000$8.80KForm 4
Dec 9, 2024Johnston John JosephDirectorSale2,495$9.46KForm 4
Dec 9, 2024Johnston John JosephDirectorOption exercise483$1.42KForm 4
Dec 9, 2024Johnston John JosephDirectorOption exercise1,121$1.84KForm 4
Dec 9, 2024Johnston John JosephDirectorOption exercise891$2.61KForm 4
Dec 6, 2024Johnston John JosephDirectorSale505$1.87KForm 4
Dec 6, 2024Johnston John JosephDirectorOption exercise505$1.48KForm 4
Nov 1, 2024Erck Stanley CDirectorSale47,689$177.40KForm 4
Nov 1, 2024Erck Stanley CDirectorOption exercise47,689$1.91KForm 4
Oct 28, 2024Johnston John JosephDirectorSale3,000$11.17KForm 4
Oct 28, 2024Johnston John JosephDirectorOption exercise3,000$8.78KForm 4
Oct 14, 2024Collins CynthiaDirectorAward51,679—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related